Seok Jin Kim

Seok Jin Kim

Sungkyunkwan University

H-index: 58

Asia-South Korea

About Seok Jin Kim

Seok Jin Kim, With an exceptional h-index of 58 and a recent h-index of 38 (since 2020), a distinguished researcher at Sungkyunkwan University, specializes in the field of lymphoma, myeloma, histiocyte, hematology, oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Current Challenges in Chimeric Antigen Receptor T-cell Therapy in Patients With B-cell Lymphoid Malignancies

Feasibility of Circulating Tumor DNA Analysis in Patients with Follicular Lymphoma

Tumor-infiltrating T lymphocytes evaluated using digital image analysis predict the prognosis of patients with diffuse large B-cell lymphoma

Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation

A novel prognostic model based on pretreatment serum albumin and ECOG PS for primary CNS lymphoma: an international, multi-center study

Current treatment patterns and the role of upfront autologous stem cell transplantation in patients with peripheral T-cell lymphoma: a Korean nationwide, multicenter …

A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide …

Prognostic Utility of Minimal Residual Disease (MRD) after Curative Intent Induction Therapy for DLBCL: A Prospective Real-World Ctdna Study

Seok Jin Kim Information

University

Position

Samsung Medical Center School of Medicine

Citations(all)

12318

Citations(since 2020)

6471

Cited By

8129

hIndex(all)

58

hIndex(since 2020)

38

i10Index(all)

250

i10Index(since 2020)

178

Email

University Profile Page

Sungkyunkwan University

Google Scholar

View Google Scholar Profile

Seok Jin Kim Skills & Research Interests

lymphoma

myeloma

histiocyte

hematology

oncology

Top articles of Seok Jin Kim

Title

Journal

Author(s)

Publication Date

Current Challenges in Chimeric Antigen Receptor T-cell Therapy in Patients With B-cell Lymphoid Malignancies

Seok Jin Kim

Sang Eun Yoon

Won Seog Kim

2024/5/5

Feasibility of Circulating Tumor DNA Analysis in Patients with Follicular Lymphoma

Cancer Research and Treatment

Sang Eun Yoon

Seung-Ho Shin

Dae Keun Nam

Junhun Cho

Won Seog Kim

...

2024/1/16

Tumor-infiltrating T lymphocytes evaluated using digital image analysis predict the prognosis of patients with diffuse large B-cell lymphoma

Journal of Pathology and Translational Medicine

Yunjoo Cho

Jiyeon Lee

Bogyeong Han

Sang Eun Yoon

Seok Jin Kim

...

2024/1

Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation

Frontiers in Oncology

Seok Jin Kim

Jae-Cheol Jo

Dok Hyun Yoon

Deok-Hwan Yang

Sang Eun Yoon

...

2023

A novel prognostic model based on pretreatment serum albumin and ECOG PS for primary CNS lymphoma: an international, multi-center study

Journal of Neuro-Oncology

Li Wei

Yuting Gao

Katharina Theresa Prochazka

Rongqiu Liu

Liang Wang

...

2023/6

Current treatment patterns and the role of upfront autologous stem cell transplantation in patients with peripheral T-cell lymphoma: a Korean nationwide, multicenter …

Cancer Research and Treatment: Official Journal of Korean Cancer Association

Hyungwoo Cho

Dok Hyun Yoon

Dong-Yeop Shin

Youngil Koh

Sung-Soo Yoon

...

2023/4

A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide …

Official journal of the American College of Gastroenterology| ACG

Yu Ri Kim

Cheolwon Suh

Dok Hyun Yoon

Deok-Hwan Yang

Yong Park

...

2023/8/1

Prognostic Utility of Minimal Residual Disease (MRD) after Curative Intent Induction Therapy for DLBCL: A Prospective Real-World Ctdna Study

Blood

Brian J Sworder

Sang Eun Yoon

Seok Jin Kim

Andre Schultz

Gregory Hogan

...

2023/11/28

A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study

Blood Research

Seok Jin Kim

Young Rok Do

Ho-Sup Lee

Won-Sik Lee

Jee Hyun Kong

...

2023/12/12

Outcomes in refractory diffuse large B-cell lymphoma: results from two prospective Korean cohorts

Blood, The Journal of the American Society of Hematology

Michael Crump

Sattva S Neelapu

Umar Farooq

Eric Van Den Neste

John Kuruvilla

...

2017/10/19

Cilta-cel or standard care in lenalidomide-refractory multiple myeloma

New England journal of medicine

Jesús San-Miguel

Binod Dhakal

Kwee Yong

Andrew Spencer

Sébastien Anguille

...

2023/7/27

TET2 and LILRB1 mutations are frequent in Epstein–Barr virus‐positive diffuse large B‐cell lymphoma especially in elderly patients

Cancer

Junhun Cho

Eojin Kim

Sang Eun Yoon

Seok Jin Kim

Won Seog Kim

2023/5/15

Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky …

Cancer Research and Treatment: Official Journal of Korean Cancer Association

Yu Ri Kim

Jin Seok Kim

Won Seog Kim

Hyeon Seok Eom

Deok-Hwan Yang

...

2023/3/30

Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma

Blood Advances

Loretta J Nastoupil

Georg Hess

Miguel A Pavlovsky

Iwona Danielewicz

Jane Freeman

...

2023/11/28

Optimizing Circulating Tumor DNA Limits of Detection for DLBCL during First Line Therapy

Blood

Jordan Goldstein

Won Seog Kim

Sang Eun Yoon

Seok Jin Kim

Mark Roschewski

...

2023/11/28

A new prognostic index for extranodal natural killer/T-cell lymphoma: incorporation of serum β-2 microglobulin to PINK

Cancer Research and Treatment: Official Journal of Korean Cancer Association

Sora Kang

Hyungwoo Cho

Shin Kim

Kyoungmin Lee

Eun Hee Kang

...

2023/1

Clinical relevance of deep learning models in predicting the onset timing of cancer pain exacerbation

Scientific Reports

Yeong Hak Bang

Yoon Ho Choi

Mincheol Park

Soo-Yong Shin

Seok Jin Kim

2023/7/17

In-depth circulating tumor DNA sequencing for prognostication and monitoring in natural killer/T-cell lymphomas

Frontiers in Oncology

Jin Ju Kim

Hyun-Young Kim

Zisun Choi

So Yoon Hwang

Hansol Jeong

...

2023/2/10

The influence of microbial dysbiosis on immunochemotherapy-related efficacy and safety in diffuse large B-cell lymphoma

Blood, The Journal of the American Society of Hematology

Sang Eun Yoon

Woorim Kang

Seunghyun Choi

Yoon Park

Mauricio Chalita

...

2023/5/4

Differences in mutational signature of diffuse large B‐cell lymphomas according to the primary organ

Cancer Medicine

Hyun‐Hee Koh

Sang Eun Yoon

Seok Jin Kim

Won Seog Kim

Junhun Cho

2023/10

See List of Professors in Seok Jin Kim University(Sungkyunkwan University)